Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition

Xie, Yan; Choi, Taeyoung; Al‐Aly, Ziyad

doi:10.1001/jamainternmed.2023.0743

Public

Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition

Published in JAMA Internal Medicine • Mar 23, 2023

Authors:

Yan Xie

Taeyoung Choi

Ziyad Al‐Aly

Abstract

Importance: Post-COVID-19 condition (PCC), also known as long COVID, affects many individuals. Prevention of PCC is an urgent public health priority. Objective: To examine whether treatment with nirmatrelvir in the acute phase of COVID-19 is associated with reduced risk of PCC. Design, Setting, and ...

Subject

Medicine

Relative risk

Hazard ratio

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!